These studies indicate that GBM tumors exhibit distinct molecular features such as telomerase reverse transcriptase (TERT) promoter mutation, epidermal growth factor receptor (EGFR) gene amplification, the combined gain of the entire chromosome 7, and the loss of the entire chromosome 10 [14,22]. The gene discussed is EGFR; the disease is glioblastoma.